These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The case for using 5-aminosalicyclates in Crohn's disease: pro.
    Author: Hanauer SB.
    Journal: Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710.
    Abstract:
    Mesalamine has a well-established role in the management of ulcerative colitis. However, its role in the management of Crohn's disease (CD) is less clear. Studies evaluating its therapeutic value in CD have produced both positive and negative results. Meta-analyses have not clarified the situation, possibly because they have combined studies of different design. This debate critically examines the evidence for and against the use of mesalamine in CD.
    [Abstract] [Full Text] [Related] [New Search]